检索

标题
作者
The post-mastectomy syndrome: the secondary lympedema after the combined treatment of breast cancer (the literature review and own results)
Stepanova A., Merzlyakova A., Khulamhanova M., Trofimova O.
Dermatomyositis and polymyositis in breast cancer patients: a case reports
Ganshina I., Zhukova L., Burnevitch E., Gordeeva O., Kondratieva O.
Eribulin for the treatment of anthracyclineand taxane-resistant breast cancer: a big step forward towards problem solving
Artamonova E.
The treatment of patients with advanced lung cancer associated with EGFR mutation
Bolotina L.
Clinico-economic evaluation of different treatment strategies in patients with non-small cell lung cancer and mutations in the EGFR gene
Ryazhenov V., Gorokhova S.
Long-term treatment of neuroendocrine tumor of the pancreas
Khvastunov R., Egorov S., Kargin A., Kim A.
The results of the first retrospective data analysis of eribulin application in patients with metastatic breast cancer in actual clinical practice in Russia
Bolotina L., Manziuk L., Gorbunova V., Kovalenko E., Mukhametshina G., Khasanova A., Vladimirova L., Mitashok I., Prokofyeva E., Evstigneeva I., Andreyashkina I., Abramova N., Popova I., Karabina E., Teterich A., Gaysina E., Chubenko V., Limareva S., Tikhanovskaya N., Storozhakova A., Samaneva N., Svetitskaya Y., Snezhko T., Kalabanova E.
Features of surgical treatment of patients with breast cancer receiving preoperative systemic therapy
Kolyadina I., Poddubnaya I., Pavlikova O., Komov D.
Adenosquamous carcinoma of the colon: case report
Nefedova N., Kharlova O., Malkov P., Kharlov N., Danilova N.
Modern possibilities of targeted therapy in metastatic colorectal cancer
Gorbunova V.
Surgical results in patients 75 years and older with gastric cancer
Rokhoev G., Stilidi I., Nered S.
The effect of combinated treatment of a metastatic HER2-positive stomach cancer
Khvastunov R., Nenarokomov A., Tolstopiatov S., Babina K.
High efficiency of lapatinib in combination with capecitabine in patient with metastatic HER2-positive synchronous breast cancer (case study)
Seryakov A., Ovchinnikova L., Zabelin M., Yakubov T., Sidorov D., Ovchinnikov M.
Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney
Klimenko A., Ivanov S.
The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)
Semiglazov V., Semiglazov V., Paltuev P., Nikolaev K., Dashyan G.
Diagram of differential diagnostics of stages of ovarian cancer
Antoneeva I., Abakumova T., Gening T., Gening S.
Refractory metastatic colorectal cancer: challenges and solutions during the COVID-19 pandemic
Sekacheva M., Fatyanova A., Meretukov D., Zhilenkova A., Rusanov A., Rozhkov A., Guryanova A., Bagmet N.
Antiangiogenic therapy for breast cancer with triple negative phenotype
Ganshina I., Ivanova K., Gordeeva O., Arkhipov A., Zhukova L.
Can any breast skin thickening be staged as T4?
Amosova V., Petrovskii A., Karpova M., Ponedel’nikova N., Frolova M.
The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib
Mazurina N., Artamonova E., Beloyartseva M., Volkova E., Ganshina I., Troshina E., Tjulandin S., Chubenko V.
Reduction of febrile neutropenia by using long-acting granulocyte colony-stimulating factors in patients with solid tumors receiving every-2-week chemotherapy
Kononenko I., Snegovoy A., Grebennikova O., Sel’chuk V., Palchinskaia O.
Virus-associated pharynx tumors in a 16-year-old boy: the description of the clinical case
Gorbunova T., Radtsig E., Merkulov O., Bogomil’skii M., Poliakov V.
The use of regorafenib in colorectal cancer
Sekacheva M., Bagmet N., Guryanova A., Rashi D.
The effectiveness of targeted therapy in the treatment of common forms of ovarian cancer
Saevets V., Vazhenin A., Chernova L., Shimotkina I., Kurchenkova O., Mukhin A., Taratonov A.
Ramucirumab therapy in patients with advanced gastric cancer: discussion of a case series
Orlova R., Zhukova L., Ganshina I., Yukalchuk D., Ponomarenko D., Beliak N., Gordeeva O., Erdniev S., Minasyan A., Dashkova A., Sopiya E., Sholokhova E., Gurochkin A.
Clinico-morphological predictors and treatment outcomes in cervical stump cancer
Usmanova L., Kuznetsov V., Mustafina E., Barinov V., Bokin I., Knyazev R., Akhmedova M.
Regorafenib application in patients with metastatic colorectal cancer in actual clinical practice
Sekacheva M., Bagmet N.
Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with paclitaxel in HER2-positive metastatic breast cancer patients: findings of the international, double-blind phase III clinical study
Ignatova E., Burdaeva O., Kopp M., Kotiv B., Udovitsa D., Stroiakovskii D., Alekseev S., Sheveleva L., Khorinko A., Shapovalova I., Moiseenko V., Ivanov R.
Choice of anti-angiogenic agents in second-line treatment in patients with metastatic colon cancer: bevacizumab, aflibercept, ramucirumab (a literature review)
Fedyanin M.
Efficacy and safety of extimia® (empegfilgrastim): results of a double-blind controlled phase iii study in patients with diagnosis «breast cancer» receiving myelosuppressive chemotherapy
Krivorotko P., Burdaeva O., Nechaeva M., Frolova M., Kopp M., Abrosimova A., Ivanov R.
Male breast cancer: review of the literature
Nikolaev K., Semiglazov V., Semiglazov V.
Radiological diagnostics of colorectal cancer liver metastases and immunohistochemical characteristics after drug treatment
Skipenko T., Paltseva E., Sekacheva M., Bedganian A.
Modern treatment possibilities of hormone receptor-positive advanced breast cancer in postmenopausal women
Jackisch C., Llombart-Cussac A.
Selection of the anti-angiogenesis therapy for the first-line chemotherapy in advanced ovarian cancer
Khokhlova S.
VEGF inhibitors: a new era in the treatment of metastatic ovarian cancer
Pignata S.
Modern possibilities of immunotherapy in the treatment of extensive-stage small cell lung cancer: experience of durvalumab application. Case report
Zhabina A., Moiseenko F., Volkov N., Abduloeva N., Moiseenko V.
Prognostic role of clinical and biological factors and parameters of hormonal profile in patients with primary inoperable HER2-negative breast cancer
Samaneva N., Vladimirova L., Kolyadina I., Frantsiyants E., Storozhakova A., Bandovkina V., Kalabanova E., Kabanov S., Svetitskaya I., Tishina A., Ezhova M.
Squamous cell breast cancer: description of a rare clinical case
Zikiryakhodjaev A., Khakimova S., Rasskazova E., Saribekian E., Omarova D., Surkova V., Khakimova G.
The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer. October 16th, 2020. Event review
Poddubnaya I., Gligorov J., Zhukova L., Kovalenko E., Frolova M.
Meta-analysis of the studies dedicated to the predictive significance of circulating tumor DNA in pancreatic cancer
Popova A., Fedyanin M., Pokataev I., Tyulyandin S.
Clinical case of long-term use of durvalumab in the treatment of advanced small-cell lung cancer
Statsenko G., Kurakin V., Plokhotenko I.
Durvalumab in the treatment of locally advanced non-small cell lung cancer after chemoradiotherapy in a real practice
Sakaeva D., Ruchkin V., Goncharova O., Abbasova R., Mufazalov F.
Differential diagnosis of lung cancer and tuberculosis: review
Belova O., Komarov I.
Olaparib in the maintenance treatment of platinum-sensitive relapse of BRCA mutant ovarian cancer in routine clinical practice: first results of observational study in Russian patients
Artamonova E., Kovalenko E., Snegovoy A., Aksarin A., Anciferova T., Belonogov A., Bilan E., Bilenko S., Varvus I., Gorkovenko E., Enikeev R., Ermolaeva A., Kramskaya L., Kononenko I., Pechenyy A., Safina S., Chupriyanova T., Chuhua G., Shemyakina A., Shikina E.
Ribociclib in 1st line HR+ breast cancer treatment
Zhukova L., Ganshina I., Gordeeva O., Lubennikova E.
Clinical cases of the treatment of metastatic colorectal cancer in Russia
Goldberg V., Hasanova A., Shkuratova V., Belevich Y., Popova N., Simolina E., Vysockaya V., Dudnikova E., Kravchuk T., Minnabetdinova R., Nekrasova O.
Brachytherapy with ultrasound assistance in patients with cervical cancer
Kizhaev Y., Razumova E., Bessolova O.
The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor
Ryazhenov V.
Circulating tumor cell: biology, methods of isolation, clinical significance in breast cancer
Nenahova Y., Lyadov V., Poddubnaya I.
Fulvestrant in endocrine therapy of recurrent and metastatic breast cancer
Vladimirova L.
The results of epidemiological screening program of HER2 status in patients with breast cancer in the federal districts of the Russian Federation in 2015
Poddubnaya I., Frank G., Yagudina R., Koroleva N., Zavalishina L.
BRCA-associated ovarian cancer (the experience of the Chemotherapy Department in N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of Russia)
Khokhlova S., Gorbunova V., Lyubchenko L., Imyanitov E.
Clinical and prognostic significance of matrix metalloproteinase-7 and vascular endothelium growth factor in patients with ovarian cancer
Knyazev R., Poddubnaya I., Bokin I., Barinov V.
Stereotactic biopsy of breast lesions under x-ray control
Manikhas G., Safronova O., Khudjakova T., Barabanova L., Punanova N.
Clinical experience with abiraterone acetate application in patients with castration-resistant prostate cancer
Gridneva Y., Matveev V., Kupchan D., Kalinin S., Peters M.
Pharmacoeconomic usefulness of the drug Giotrif® (afatinib) in first-line treatment of locally advanced or metastatic non-small cell lung cancer with a mutation of epidermal growth factor receptor (EGFR)
Kolbin A., Kurylev A., Pavlysh A., Proskurin M., Balykina Y.
HER2-positive disseminated gastric and gastro-oesophageal junction adenocarcinoma: forecast, clinical course, treatment
Besova N.
The results of Epidemiological HER2 screening program in patients with breast cancer in 2013
Frank G., Poddubnaya I., Yagudina R., Borisov D., Koroleva N.
RADIOTHERAPY AS THE ONLY TREATMENT IN CASE OF TONGUE CANCER PATIENTS
Garbuzov M.
Surgical stading local – cervical cancer incidence
Kargopolova M., Maximov S., Berlev I., Boyarkina M., Meshkova I., Khadzhimba A., Novikov S., Krzhivitsky P., Ponomareva O., Urmancheeva A., Ivanzov A., Guseynov K., Vishinskaya E., Matveeva N.
Combined and complex treatment options for patients with operable rectal cancer
Barsukov Y., Tkachev S., Mamedli Z., Kuzmichev D., Aliev В., Kim D.
Isolated splenic metastases from colon cancer: clinical observations
Ognerubov N., Antipova T., Ognerubova M.
Analysis of the efficacy and safety of eribulin therapy in patients with HR+/HER2- metastatic breast cancer pretreated with CDK4/6 inhibitors in real Russian practice
Kolyadina I., Abidova N., Akopyan A., Antonova G., Arapova O., Bobrova E., Bolotina L., Valiakhmetova C., Vasilevskaya A., Vladimirova L., Volkonskiy M., Ganshina I., Gudkova I., Dergunov A., Evstigneeva I., Egurenkova V., Emshanov A., Zhukova L., Zueva E., Karabina E., Kolokolov J., Kuzmicheva S., Kuchevskaya O., Luev I., Maistrenko K., Markizova E., Marfutov V., Medvedev S., Merzlikina Y., Nersesova T., Ovchinnikova E., Orlova S., Samaneva N., Stativko O., Storozhakova A., Stroyakovskiy D., Sultanbaev A., Tekeeva A., Fadeeva N., Fedorova A., Shalaeva O., Shangina I., Shirokova O., Shumskikh A., Yakubova M.
Vulvar cancer: brain metastases. Clinical observation
Ognerubov N., Antipova T., Kamneva N.
Differentiated thyroid cancer
Bel’tsevich D., Mudunov A., Vanushko V., Rumiantsev P., Mel’nichenko G., Kuznetsov N., Podvyaznikov S., Alymov Y., Poliakov A., Fadeev V., Bolotin M., Sevriukov F., Krylov V., Fedenko A., Bolotina L., Zharov A., Falaleeva N., Filonenko E., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T.
Use of nivolumab for colon cancer with Lynch syndrome
Khakimov G., Tryakin A., Khakimova G.
Clinical case of long-term use of osimertinib in the treatment of EGFR mutation-positive lung adenocarcinoma
Odintsova S., Sviridenko M., Cheremnykh A., Filippova E., Urtenova M., Orlov S.
Molecular-biological marker Bcl-2 in colorectal cancer: the characteristics, the role of mechanisms regulating apoptosis, the effect on the prognosis (review of literature)
Darenskaia A., Dobrova N., Stepanova E.
Pneumonectomy with carinal resection in patients with non-small cell lung cancer: short and long-term results
Dadyev I., Davydov M., Abdullaev A., Kulik I., Ambalova Z., Akhmedov P., Anokhin A., Karasheva B.
The evolution of views on the possibilities of drug therapy in overcoming acquired resistance not associated with Т790М mutation to anti-EGFR drugs in non-small cell lung cancer
Karabina E., Lubchenko L., Garunov A.
Case studies on clinical experience of targeted therapy ribociclib in combination with letrozole in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
Frolova M., Kochetkova Y., Chubenko V., Volkov N., Moiseenko F., Garmarnik T., Ponomarenko D., Orlov A., Kostalanova Y., Makarycheva Y., Nizegorodzeva A.
Soft tissue metastases of the gluteal region in HER2+ breast cancer: a clinical case
Kolyadina I., Ganshina I., Zhukova L., Abdullaev A., Andreeva Y., Danzanova T., Sinyukova G., Komov D., Kozlov N., Filonenko D., Gordeeva O., Lubennikova E.
Regorafenib: from clinical research to clinical practice
Fedyanin M., Tryakin A.
Pharmacoeconomic characteristics of ixabepilone (Ixempra) monotherapy in patients with locally advanced and metastatic breast cancer resistant to treatment with anthracyclines, taxanes and capecitabin
Kolbin A., Mosikyan A., Kurilev A., Balykina Y., Proskurin M.
The role of regorafenib in the treatment of metastatic colorectal cancer
Tryakin A.
Development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype
Karabina E., Zhukova L.
The optimization of second-line therapy for metastatic colorectal cancer: new targeted therapy options
Artamonova E., Manzyuk L.
Hereditary ovarian cancer
Demidova I.
Brain metastases in her2-positive breast cancer: new opportunities for systemic therapy
Artamonova E., Manziuk L.
Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer
Semiglazova T., Dashyan G., Semiglazov V., Zhabina A., Osipov M., Kotova Z., Klimenko V., Krivorotko P., Semiglazov V.
Bevacizumab in advanced ovarian cancer: when, what for and why?
Tjulandina A.
Modern possibilities of HER2 positive breast cancer treatment (based on clinical trials)
Kolyadina I., Poddubnaya I.
Difficulties in treating patients with breast cancer in Russia: the resolution on the results of the Review Board
Artamonova E., Gorbunova V., Zhukov N., Manzjuk L., Manihas A., Paltuev P., Semiglazov V., Semiglazova T., Stenina M., Tjuljandin S., Chubenko V.
New chemotherapy options for triple-negative breast cancer (review of literature)
Sekundova M., Zdvizhkov A., Borisov V.
Results of preoperative antitumor therapy in combination with bevacizumab and KRAS status during liver resections for colorectal cancer metastases
Sekacheva M., Bagmet N., Polishchuk L., Glazova O., Zaklyazminskaya E., Skripenko O.
Current approach to adjuvant therapy for breast cancer (a review)
Conte P., Guarneri V.
Telephone interventions for symptom management in adults with cancer (Russian Translation of Cochrane Plain Language Summary – PLS)
Lapshina D.
Comparison of afatinib and osimertinib effect on overall survival in first-line drug treatment of EGFR-positive metastatic non-small cell lung cancer: network meta-analysis
Goryaynov S.
Prostate cancer
Kaprin A., Alekseev B., Matveev V., Pushkar’ D., Govorov A., Gorban’ N., Kirichek A., Biriukov V., Volkova M., Gulidov I., Gumenetskaia I., Krylov V., Kariakin O., Krasheninnikov A., Mardynskii I., Niushko K., Zakharova T., Kostin A., Khmelevskii E., Fedenko A., Bolotina L., Falaleeva N., Filonenko E., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T.
Treatment of metastatic hepatocellular carcinoma with lenvatinib. Case report and literature review
Menshikov K., Sultanbaev A., Akhmetgareeva K., Lipatov D.
The frequency and spectrum of PIK3CA mutations in patients with estrogen receptor-positive HER2-negative advanced breast cancer residing in various regions of Russia
Sokolova T., Aleksakhina S., Yanus G., Sultanbaev A., Menshikov K., Lysenko A., Zukov R., Zyuzyukina A., Murunova Y., Rossokha E., Bakharev S., Basova E., Kasmynina T., Shumskaya I., Bakshun Y., Musaeva K., Khasanova A., Dmitriev V., Bolieva M., Gadzaova C., Petrenko O., Maksimov D., Vladimirov V., Goldberg V., Popova N., Kibisheva M., Khamgokov Z., Vasilyev A., Iyevleva A., Imyanitov E.
Cancer of an ectopic parathyroid gland: from diagnosis to treatment (clinical case)
Allakhverdiev A., Malkina N., Noskova K., Grinevich V., Feidorov I., Ketsba A., Bystrovskay E., Embutniex Y., Putova M., Synkova D.
The relationship of GITR, Lag-3 and PD-1 expression with the main indicators of systemic and local immunity in patients with breast cancer
Tabakov D., Zabotina T., Chanturia N., Zakharova E., Vorotnikov I., Selchuk V., Sokolovskiy V., Petrovsky A.
Adjuvant targeted therapy for non-small cell lung cancer
Laktionov K., Kazakov A., Gordiev M., Kononets P., Akhmedov B., Maevskaia J.
The predictive value of digital mammography, breast ultrasound and their combination in the diagnosis of early breast cancer
Alieva G., Korzhenkova G., Kolyadina I.
The first experience of immunotherapy application of ipilimumab in combination with chemotherapy of small-cell lung cancer in the Russian population. Analysis of the combined data of two centers, participating in the multicenter randomized phase III study СА 184-156
Kuzminov A., Gorbunova V., Poddubskaya E., Bagrova S., Baranova M., Laktionov K.
Optimal duration of adjuvant trastuzumab therapy in patients with HER2-possitive early breast cancer: whether the problem is resolved?
Zhukova L., Ganshina I., Khatkova E., Tikhomirova T., Kondratyeva O.
Irreversible electroporation of locally advanced unresectable pancreatic cancer
Patyutko Y., Polyakov A., Kudashkin N., Podluzhnyi D., Chistyakova O.
Olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer
Khokhlova S.
Tracheal and bronchial plastic resection in patients with lung cancer
Khvastunov R., Usachev A.
201 - 300 的 334 信息 << < 1 2 3 4 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##